C.Cg-Tg(Igh-VSp6/IGHM)39Corc/Orl

Status

Available to order

EMMA IDEM:01371
Citation informationRRID:IMSR_EM:01371 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC.Cg-Tg(Igh-VSp6/IGHM)39Corc/Orl
Alternative namehmuSp6
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Igh-VSp6/IGHM)39Corc
Gene/Transgene symbolTg(Igh-VSp6/IGHM)39Corc

Information from provider

ProviderDaniel Corcos
Provider affiliationER70 CNRS et Unite 125 Inserm
Genetic informationThe hmuSp6 construct encodes a human immunoglobulin mu heavy chain with a mouse Sp6 variable region.
Phenotypic informationExpression of the hmuSp6 constructs leads to allelic exclusion of endogenous gene. B cell development is close to normal.
Breeding historyBackcrossed to BALB/c for at least 10 generations. Currently bred as homozygous.
References
  • Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.;Corcos D, Dunda O, Butor C, Cesbron J Y, Lorès P, Bucchini D, Jami J, ;1995;Current biology : CB;5;1140-8; 8548286
  • Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.;Corcos D, Grandien A, Vazquez A, Dunda O, Lorès P, Bucchini D, ;2001;Journal of immunology (Baltimore, Md. : 1950);166;3083-9; 11207259

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Literature references

  • Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.;Corcos D, Dunda O, Butor C, Cesbron J Y, Lorès P, Bucchini D, Jami J, ;1995;Current biology : CB;5;1140-8; 8548286
  • Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.;Corcos D, Grandien A, Vazquez A, Dunda O, Lorès P, Bucchini D, ;2001;Journal of immunology (Baltimore, Md. : 1950);166;3083-9; 11207259

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).